Money Matters - Simplified

What Investors Think About BioScrip


To help you out, we've created a screen based on the massive data aggregated from the more than 165,000 investors competing on our Motley Fool CAPS platform. Each quarter, we check in on select companies after they file a 10-Q and track community sentiment to help you see how your company is doing.

Here's our CAPS community's sentiment on BioScrip(Nasdaq: BIOS) both for this quarter and last (for comparison), as well as opinions on some related companies.

Metric BioScrip inVentiv Health(Nasdaq: VTIV) VCA Antech(Nasdaq:WOOF) Kindred Healthcare(NYSE: KND)
This Quarter (8/3/2010):
Price: $4.17 $25.96 $20.52 $12.91
% of Members Rating Outperform 89% 98% 94% 94%
% of All-Star Members Rating Outperform 97% 99% 97% 98%
CAPS Rating (out of 5) **** ***** **** ****
Last Quarter (5/5/2010):
Price: $7.85 $24.25 $27.52 $17.01
% of Members Rating Outperform 87% 98% 95% 94%
% of All-Star Members Rating Outperform 93% 99% 98% 98%
CAPS Rating (out of 5) ** ***** **** ****

Source: Motley Fool CAPS. Dates given are the posting dates of BioScrip's most recent quarterly and/or annual reports to the SEC's website. Percentages are calculated from the number of members rating each company.

A change in the community's approval (signified by four- and five-star ratings) or disapproval (one- and two-star ratings) could indicate that further research is in order. To help make your research easier…

  • Share any thoughts you have about BioScrip -- or any of the other companies mentioned -- in the comments box below.
  • Head over to the completely free CAPS service -- a one-stop research shop -- and read what your fellow investors are saying about your stocks.

© 2010 UCLICK L.L.C.